Contents
Issue 160 • November 2025
In association with
In Depth
Cleanrooms reimagined: Inside pharma manufacturing’s new era
Sustained interest? Biopharma’s green manufacturing gains traction
Bioproduction booms: How innovation is redefining biologics, vaccines and therapeutics
From Nobel to next-gen: Sweden’s quiet life sciences ascent
ESMO25: Keytruda combo defies doubt, delivers PFS and OS gains in ovarian cancer
‘The time of the Einsteins is over’: Pharma urged to rethink trials for 2050
Biopharmaceutical industry cold-chain networks an innovation hotbed